Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis

Gu Jieruo126 enrolled

Overview

This is a prospective randomized controlled study to evaluated the efficacy and safety of kunxian capsule in treating of patients with early ankylosing spondylitis (AS). The major outcome index is proportion of patients achieving ASAS20 response at week12, and minor outcome indexes include ASAS50 and ASAS70, BASDAI20,BASDAI50 and BASDAI70. The adverse events at any time were recorded to evaluate the safety.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

126

Conditions

Ankylosing Spondylitis Treatment

Interventions

kunxian capsuleDRUG

The main element of kunxian capsule is Tripterygium. Patients should take 2 tablets per time and 3 times per day for 12 weeks.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 16 to 65 years old, having signed the informed consent; * fulfill the ESSG criteria for diagnosis of SpA; not fulfill the 1984 modified NewYork criteria for AS; * BASDAI score more than 4; * stop taking DMARDs for at least 4 weeks; * NSAIDs dosage has been stable for at least 4 weeks; Exclusion Criteria: * Intra-articular injection of cortisone within 3 months. * History of heart failure, multiple sclerosis, COPD, lymphoma or other tumors; * Accompanied by fibromyalgia or other rheumatic diseases; * Female of pregnancy or breast feeding; * History of mental disease and poor compliance. * History of drug abuse or alcoholism.

Locations (1)

Rheumatology Department, the Third Affiliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, China

Outcomes

Primary Outcomes

proportion of patients achieving ASAS20 response

Time frame: 12th week

Secondary Outcomes

proportion of patients achieving BASDAI20/50/70 response

Time frame: 12th week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.